Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biosurveillance

    Emerging Infections Sentinel Networks Research Funding for Emergency Departments

    By Global Biodefense StaffOctober 3, 2021
    Dr. Jeffery Lawson, an emergency room physician, evaluates a notional patient during a hospital exercise. Credit: Jorge Garcia
    Share
    Facebook LinkedIn Reddit Email

    The Centers for Disease Control and Prevention is providing a funding mechanism to assist emergency departments in their role as provider-based sentinel networks as part of the Emerging Infections Sentinel Networks (EISN) program.

    These works will contribute to surveillance for emerging infectious diseases, such as those caused by drug-resistant, foodborne or waterborne microorganisms, and vaccine-preventable or potentially vaccine-preventable diseases (e.g., Clostridium difficile, carbapenem-resistant Enterobacteriaceae [CRE], viral hepatitis, tuberculosis, sexually transmitted diseases).

    Emergency departments are considered an invaluable source of infectious disease data for several reasons: EDs treat large numbers of persons, persons with acute and severe disease, persons with clinical syndromes, persons with community-acquired infections, and at-risk populations; EDs can collect prospective data in real time and usually have hospital laboratories available to them; and EDs can also serve as the first line of detection and defense from public health threats and emerging infectious diseases.

    These emergency departments will contribute to information for public health emergency preparedness and response through operational research on topics such as ED rapid triage, throughput, and surge capacity ( e.g., assess the clinical characteristics, impacts and outcomes of new and emerging diseases). In addition, frontline clinicians will help better address the disproportionate impact of emerging infectious diseases (EIDs) on underserved and disadvantaged populations.

    Public Health Impact

    EISNs contribute to public health by ensuring recommendations are implementable in routine and emergency frontline healthcare settings; generating practical information for action; building capacity and clinical acumen to detect unusual events; and helping clinicians determine when it is appropriate to activate the public health system.

    The funding mechanism is U01 Research Project Cooperative Agreements from the CDC’s National Center for Emerging and Zoonotic Infectious Diseases (RFA-CK-22-003). The closing date for applications is 19 Oct 2021.

    C. diff CRE Editor Pick Emerging Threats Epidemiology Frontline Responders Tuberculosis Viral Hepatitis
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleVaccination Significantly Reduces Risk of Developing Long COVID
    Next Article Dynavax and DoD Announce Collaboration to Develop an Adjuvanted Plague Vaccine

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.